Search the NeLM

Medicines A-Z
Find key information about medicines by name (prototype)
NeLM news service
New Drug Submission for 6-month triptorelin depot filed in Canada

Source: BioSpace

Date published: 10/03/2009 14:34

Summary
by: Nicola Pocock

According to BioSpace, a new drug submission for Trelstar® 22.5 mg (6-month slow release depot of triptorelin) for the palliative treatment of advanced prostate cancer has been filed in Canada.

About this library entry
Category: 6.7.2 Drugs affecting gonadotrophins | Cancer: prostate | New drugs
NeLM area:  News
Link

Preview your comment

Add new comment

Comment text:

Comments

There are no comments yet. You could be the first! You must be Logged In to comment.
Back